Log inSign up
Home/Library/Metabolic/Tirzepatide

Tirzepatide

Popular

Dual GIP/GLP-1 receptor agonist

4.7138 reviews
Research use only Third-party tested
CategoryMetabolic
Half-life~5 days
FormatLyophilized
Storage2-8°C
Purity>99%

Research context

Has robust human trial data and FDA-approved prescription indications. Community results still cannot prove causation for an individual.

  • Large weight-loss before/after posts and maintenance discussions.
  • Appetite reduction and glycemic-control claims within labeled prescription use.
  • Online compounding discussions, which require careful legal and quality review.

Evidence snapshot

See full evidence tab
Clinical Studies
62
Animal Studies
48
In Vitro Studies
31
Reviews / Meta-analyses
18

Last updated: June 2025

Quick facts

Aliases
LY3298176
Molecular weight
4813.5 g/mol
Sequence length
39 amino acids
Product type
Synthetic
CAS / Registry
TBD
Appearance
White lyophilized powder
Solubility
Water

Safety notes

For research use only. Not for human or veterinary use.

  • Common research observations: nausea, reduced appetite, GI discomfort
  • Monitor hydration and nutrient intake in long-term studies
  • Consult current literature for full safety profile and contraindications

Popular research protocols

View all protocols
Weight Management Research5-15 mg weekly
Metabolic Research Protocol2.5-10 mg weekly
Extended Study Protocol5-20 mg weekly
Combination Research ProtocolTBD
Research use onlyAll peptides are intended for laboratory research purposes only. Not for human or veterinary use.